Type 2 Diabetes Clinical Trial
Official title:
More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus
Rady Children's Hospital San Diego (RCHSD), UCSD Division of Child and Community Health and the Center for Community Health, and Northgate Gonzalez (NG) Markets will collaborate to create a Produce Prescription Program (Fruit and Vegetable Prescription Program) to be implemented in the RCHSD Diabetes Clinic. We will provide families on Medi-Cal who have a child with T2DM with a fruit and vegetable prescription (FVRx) which will enhance their ability to purchase GusNIP-eligible fresh fruits and vegetables (FV). These prescriptions will be delivered in the form of an electronic voucher that can be filled at any NG Markets throughout San Diego and Riverside counties. The goal of this program is to increase the purchase and consumption of fresh fruits and vegetables, decrease food insecurity, and improve metabolic outcomes for children with type 2 diabetes mellitus (T2DM).
Status | Recruiting |
Enrollment | 200 |
Est. completion date | August 31, 2025 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility | Inclusion Criteria: - Age < 18 years old - Diagnosis of type 2 diabetes mellitus - Hemoglobin A1c greater than or equal to 6.5 - Receiving care at the Rady Children's Hospital Diabetes Clinic Exclusion Criteria: - Another immediate family member living in the same household who is already recruited into the study |
Country | Name | City | State |
---|---|---|---|
United States | Rady Children's Hospital San Diego | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Diego | Rady Children's Hospital, San Diego, United States Department of Agriculture (USDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Household food security | 18-item US Household Food Security Survey Module | Survey will be completed at baseline and 12 months | |
Primary | Change in Hemoglobin A1c | Point of care A1c | Measured as part of the participant's routine care in the Diabetes Clinic at baseline and 12 months | |
Secondary | Change in BMI z-score | BMI calculated by measured height and weight and converted to BMI z-score | Measured at baseline and 12 months as part of the participant's routine care in the Diabetes Clinic | |
Secondary | Change in Total cholesterol | Serum Total cholesterol | Measured at baseline and 12 months as part of the participant's routine care in the Diabetes Clinic | |
Secondary | Change in Liver function tests | Serum aspartate transaminase (AST), serum alanine transaminase (ALT) | Measured at baseline and 12 months as part of the participant's routine care in the Diabetes Clinic | |
Secondary | Change in Blood pressure | Systolic and diastolic BP | Measured at baseline and 12 months as part of the participant's routine care in the Diabetes Clinic | |
Secondary | Change in beta carotene | serum beta carotene levels | Measured at baseline and 12 months | |
Secondary | Change in fruit and vegetable intake | Change in child fruit and vegetable intake as measured by the DSQ | Survey will be completed at baseline and 12 months. | |
Secondary | Change in HDL cholesterol | Serum HDL cholesterol | Measured at baseline and 12 months as part of the participant's routine care in the Diabetes Clinic |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |